Domingues Rosa Maria Soares Madeira, Dias Marcos Augusto Bastos, Pereira Ana Paula Esteves, Luz Paula Mendes, Jalil Emilia M, Rabello Angela Cristina Vasconcelos de Andrade, Friedman Ruth Khalili, Leal Maria do Carmo
Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Pesquisa Clínica em HIV, Aids, Infecções Sexualmente Transmissíveis e Hepatites, Rio de Janeiro, RJ, Brazil.
Fundação Oswaldo Cruz, Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira, Rio de Janeiro, RJ, Brazil.
Braz J Infect Dis. 2025 May-Jun;29(3):104522. doi: 10.1016/j.bjid.2025.104522. Epub 2025 Mar 28.
Gestational (GS) and congenital syphilis (CS) are important public health problems in Brazil. This study aims to estimate the prevalence of GS, the incidence of CS and the rate of vertical transmission (VT) of syphilis, as well as to evaluate the management indicators of GS in the State of Rio de Janeiro (RJS), the Brazilian state with the highest detection rate of GS and incidence of CS in 2022. A hospital-based, cross-sectional study was carried out in public and private hospitals located in RJS, in the period 2021-2023, with interviews with 1,923 women, analysis of prenatal care (PNC) cards and hospital records. The GS management indicators, the prevalence of GS, the incidence of CS and the rate of VT were estimated with the respective 95 % confidence intervals (95 % CI), according to the source of financing for hospitalizations for childbirth or abortion care. PNC was reported by 93.7 % of women, 82.7 % had the first test for syphilis and 52.6 % the second. The prevalence of GS was estimated at 14.5 % (95 % CI 9.2 %- 22.2 %), with higher values in women with public financing (18.2 % public; 3.6 % private). Nearly one-third-of women with GS were diagnosed only during hospitalization for childbirth or abortion care and 13.4 % were appropriately treated during PNC. The incidence of CS was estimated at 53.1 per 1,000 live births (68.4 per 1,000 public; 9.7 per 1,000 LB private) with a VT rate of 33.5 %, with no difference according to the source of financing. The detection rate of GS and the incidence rate of CS were double those reported to the Brazilian Notifiable Diseases Information System. Several missed opportunities for the control of CS were identified. Women with public financing had a higher prevalence of GS and incidence of CS, and should be the priority target of control strategies.
妊娠梅毒(GS)和先天性梅毒(CS)是巴西重要的公共卫生问题。本研究旨在估计妊娠梅毒的患病率、先天性梅毒的发病率以及梅毒的垂直传播率(VT),并评估里约热内卢州(RJS)妊娠梅毒的管理指标。里约热内卢州是2022年巴西妊娠梅毒检出率和先天性梅毒发病率最高的州。2021年至2023年期间,在里约热内卢州的公立和私立医院开展了一项基于医院的横断面研究,对1923名女性进行了访谈,并分析了产前保健(PNC)卡和医院记录。根据分娩或流产护理住院的资金来源,估计了妊娠梅毒管理指标、妊娠梅毒患病率、先天性梅毒发病率和垂直传播率及其各自的95%置信区间(95%CI)。93.7%的女性报告了产前保健情况,82.7%的女性进行了首次梅毒检测,52.6%的女性进行了第二次检测。妊娠梅毒患病率估计为14.5%(95%CI 9.2%-22.2%),公共资金资助的女性患病率更高(公共资金资助的为18.2%;私人资金资助的为3.6%)。近三分之一的妊娠梅毒女性仅在分娩或流产护理住院期间被诊断出来,13.4%的女性在产前保健期间得到了适当治疗。先天性梅毒发病率估计为每1000例活产53.1例(每1000例公共资金资助的活产68.4例;每1000例私人资金资助的活产9.7例),垂直传播率为33.5%,资金来源不同无差异。妊娠梅毒的检出率和先天性梅毒的发病率是向巴西法定传染病信息系统报告的两倍。发现了一些控制先天性梅毒的错失机会。公共资金资助的女性妊娠梅毒患病率和先天性梅毒发病率更高,应成为控制策略的优先目标人群。